In a murine model of SLE comparing CD40 antagonist antibody and the anti-inflammatory drug prednisolone, administration of CD40 antagonist antibody restored proteinuria, survival rate, and glomerular morphology, whereas prednisolone treatment alone was shown to have limited benefits [96]. This evidence concerns the gene CD40 and systemic lupus erythematosus.